Cannabigerol - 20 mg/ml solution in methanol
CAS: 25654-31-3
Rif. 3D-FC42726
5mg | 136,00 € | ||
10mg | 177,00 € | ||
25mg | 352,00 € | ||
50mg | 548,00 € | ||
100mg | 970,00 € |
Informazioni sul prodotto
- CBG
- (E)-2-(3,7-Dimethylocta-2,6-dien-1-yl)-5-pentylbenzene-1,3-diol
- 1,3-Benzenediol, 2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-
- 1,3-Benzenediol, 2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-, (E)-
- 1,3-Benzenediol, 2-[(2E)-3,7-dimethyl-2,6-octadien-1-yl]-5-pentyl-
- 1,3-Benzenediol, 2-[(2E)-3,7-dimethyl-2,6-octadienyl]-5-pentyl-
- 2-((2E)-3,7-Dimethylocta-2,6-dienyl)-5-pentylbenzene-1,3-diol
- 2-[(2E)-3,7-Dimethyl-2,6-octadien-1-yl]-5-pentyl-1,3-benzenediol
- Cannabigerol
- Resorcinol, 2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-
- Vedi altri sinonimi
- Resorcinol, 2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-, (E)-
Cannabigerol is a non-psychotropic phytocannabinoid which has a low affinity for the CB1 and CB2 receptors but affects the endocannabinoid system by inhibiting anandamide uptake (Morales, 2017). It also acts as a potent alpha2+adrenoceptor agonist (EC50= 0.2 nM) (Cascio, 2010). In vitro, cannabigerol was shown to reduce cell loss viability and inhibit apoptosis in motor neurons as well as reducing inflammatory cytokine levels in neural cultures. In in vivo experimental animal models it was shown to antagonize the 5-HT1A receptor (Kb= 51.9 nM) (Cascio, 2010), inhibit vas deferens contractions via a2 adrenoceptor mediation as well as improve motor deficits and prevent neurotoxicity and the upregulation of proinflammatory markers on striatal neurons in mice models (Valdeolivas, 2015).
Proprietà chimiche
Richiesta tecnica su: 3D-FC42726 Cannabigerol - 20 mg/ml solution in methanol
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.